Business Description
Zylox-Tonbridge Medical Technology Co Ltd
ISIN : CNE100004JD2
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 27.04 | |||||
Equity-to-Asset | 0.9 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.73 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 6.68 | |||||
Beneish M-Score | -2.07 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 159.1 | |||||
3-Year EBITDA Growth Rate | 25.2 | |||||
3-Year EPS without NRI Growth Rate | 14.7 | |||||
3-Year FCF Growth Rate | 13 | |||||
3-Year Book Growth Rate | 75.3 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 82.84 | |||||
9-Day RSI | 71.59 | |||||
14-Day RSI | 66.1 | |||||
6-1 Month Momentum % | -22.61 | |||||
12-1 Month Momentum % | -5.99 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.4 | |||||
Quick Ratio | 4.88 | |||||
Cash Ratio | 4.75 | |||||
Days Inventory | 378.06 | |||||
Days Sales Outstanding | 0.73 | |||||
Days Payable | 69.96 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -7.2 | |||||
Shareholder Yield % | 0.85 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 72.95 | |||||
Operating Margin % | -27.37 | |||||
Net Margin % | -14.92 | |||||
FCF Margin % | -17.52 | |||||
ROE % | -2.54 | |||||
ROA % | -2.36 | |||||
ROIC % | -9.62 | |||||
ROC (Joel Greenblatt) % | -16.67 | |||||
ROCE % | -2.49 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 6.64 | |||||
PB Ratio | 1.12 | |||||
Price-to-Tangible-Book | 1.14 | |||||
Price-to-Operating-Cash-Flow | 35.45 | |||||
EV-to-EBIT | -26.03 | |||||
EV-to-EBITDA | -26.26 | |||||
EV-to-Revenue | 3.82 | |||||
EV-to-FCF | -20.32 | |||||
Price-to-Net-Current-Asset-Value | 2.46 | |||||
Price-to-Net-Cash | 2.89 | |||||
Earnings Yield (Greenblatt) % | -3.84 | |||||
FCF Yield % | -2.68 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Zylox-Tonbridge Medical Technology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 577.247 | ||
EPS (TTM) (HK$) | -0.262 | ||
Beta | 0 | ||
Volatility % | 57.53 | ||
14-Day RSI | 66.1 | ||
14-Day ATR (HK$) | 0.466975 | ||
20-Day SMA (HK$) | 10.646 | ||
12-1 Month Momentum % | -5.99 | ||
52-Week Range (HK$) | 7.2 - 14.66 | ||
Shares Outstanding (Mil) | 327.39 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Zylox-Tonbridge Medical Technology Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Zylox-Tonbridge Medical Technology Co Ltd Stock Events
Event | Date | Price(HK$) | ||
---|---|---|---|---|
No Event Data |
Zylox-Tonbridge Medical Technology Co Ltd Frequently Asked Questions
What is Zylox-Tonbridge Medical Technology Co Ltd(HKSE:02190)'s stock price today?
When is next earnings date of Zylox-Tonbridge Medical Technology Co Ltd(HKSE:02190)?
Does Zylox-Tonbridge Medical Technology Co Ltd(HKSE:02190) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |